1933 Industries Inc (TGIFF)
0.0125
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
1933 Industries Profit Margin (Quarterly): -15.62% for Jan. 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | -15.62% |
October 31, 2023 | -6.58% |
July 31, 2023 | -177.7% |
April 30, 2023 | -76.69% |
January 31, 2023 | -9.36% |
October 31, 2022 | -21.43% |
July 31, 2022 | -139.9% |
April 30, 2022 | -290.7% |
January 31, 2022 | -25.99% |
October 31, 2021 | -38.64% |
July 31, 2021 | -110.1% |
April 30, 2021 | 11.54% |
January 31, 2021 | -41.36% |
October 31, 2020 | -99.84% |
July 31, 2020 | -293.6% |
April 30, 2020 | -181.5% |
January 31, 2020 | -195.5% |
October 31, 2019 | -96.82% |
July 31, 2019 | -104.2% |
April 30, 2019 | -153.7% |
January 31, 2019 | -80.27% |
October 31, 2018 | -67.04% |
July 31, 2018 | -98.99% |
April 30, 2018 | -18.00% |
January 31, 2018 | -25.32% |
Date | Value |
---|---|
October 31, 2017 | -24.33% |
July 31, 2017 | -195.4% |
April 30, 2017 | |
January 31, 2017 | |
October 31, 2016 | |
July 31, 2016 | |
April 30, 2016 | |
January 31, 2016 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-293.6%
Minimum
Jul 2020
11.54%
Maximum
Apr 2021
-103.4%
Average
-98.33%
Median
Profit Margin (Quarterly) Benchmarks
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | -59.60% |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | -448.0% |
Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -59.83% |
Return on Invested Capital | -392.4% |
Gross Profit Margin (Quarterly) | 29.61% |
Operating Margin (Quarterly) | -5.38% |
Return on Net Operating Assets | -59.83% |